The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Practical Considerations for Recognizing and Managing Severe Irritable Bowel Syndrome
Abstract
Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal pain or discomfort and altered bowel habit (chronic or recurrent diarrhea, constipation, or both) that occurs more frequently in women than in men. Severe IBS may be underrecognized and inadequately managed in clinical practice. Although no consensus definition for "severe IBS" exists, patients may be categorized as having severe illness if they show an insufficient response to conventional treatments or if their functionality or quality of life is impaired as a result of their IBS symptoms. Nurses can be an important resource in optimizing the evaluation and treatment of these patients. Nursing assessments that delineate predominant symptoms and the history and nature of prior interventions (e.g., lifestyle changes, over-the-counter or prescription medication trials, psychotherapy, alternative treatments) and subsequent responses are important when advising patients and participating in the management of their IBS. Likewise, the nurse's assessment should include a history of symptom severity and impact on daily functioning, as these elements are important to choosing therapy. The nurse-patient dialogue should also include a description of available treatment options and the benefits and risks associated with each. By maintaining such a dialogue, nurses can hasten IBS recognition, improve management, limit the negative consequences of this common disorder, and improve overall treatment outcomes in this population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
Kaptchuk, T. J., Kelley, J. M., Conboy, L. A., Davis, R. B., Kerr, C. E., Jacobson, E. E., Kirsch, I., Schyner, R. N., Nam, B. H., Nguyen, L. T., et al. (2008) · BMJ · doi:10.1136/bmj.39524.439618.25 · Cited by 1,196
Whitehead, W. E., Palsson, O., & Jones, K. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.32392 · Cited by 1,116
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
Whorwell, P. J., Altringer, L., Morel, J., Bond, Y., Charbonneau, D., O'Mahony, L., Kiely, B., Shanahan, F., & Quigley, E. M. M. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00734.x · Cited by 799
The impact of irritable bowel syndrome on health-related quality of life
Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · cited 1×
“Research has highlighted levels of impairments in health-related QoL and physical role limitations in IBS that are similar to, or greater than, those found in other chronic diseases, such as diabetes mellitus (Gralnek, Hays, Kilbourne, Naliboff, & Mayer, 2000) or major depressive disorder (Gralnek et al., 2000).”
BackgroundAn Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome
American College of Gastroenterology IBS Task Force (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.122 · Cited by 694
Pimentel, M. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05902-6 · Cited by 669
Our new president—Jon I. Isenberg, M.D
Boland, C. R., & Yamada, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.24057 · Cited by 629
Ford, A. C., Talley, N. J., Schoenfeld, P. S., Quigley, E. M. M., & Moayyedi, P. (2009) · Gut · doi:10.1136/gut.2008.163162 · Cited by 582
Research works printed but not linked: 1
- Spiegel, 2010, Patient-reported symptom relief from current therapy is a robust marker of illness severity in IBS abstract 865., Gastroenterology, 5, S119
Cited by
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Vasant, D. H., Paine, P. A., Black, C. J., Houghton, L. A., Everitt, H. A., Corsetti, M., Agrawal, A., Aziz, I., Farmer, A. D., Eugenicos, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-324598 · Cited by 592
Asal, M. G. R., El‐Sayed, A. A. I., Alsenany, S. A., Ramzy, Z. H., & Dawood, R. F. A. (2025) · BMC Nursing · doi:10.1186/s12912-024-02594-5 · Cited by 10
Moore, J. S., Gagan, M. J., & Perry, R. E. (2014) · Gastroenterology Nursing · doi:10.1097/sga.0000000000000073 · Cited by 10
Usher, L., Fox, P., Lafarge, C., & Mitchell, K. (2013) · Psychology Community & Health · doi:10.5964/pch.v2i3.65 · Cited by 10
Harris, L. A., & Umar, S. B. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1498-2_16 · Cited by 7
Self-citation
Metadata
- Authors
- Harris, L. A., & Heitkemper, M. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Harris, Lucinda A.
- Venue
- Gastroenterology Nursing
- Published
- 2012-01
- Volume
- 35
- Issue
- 1
- Pages
- 12-21
- ISSN
- 1042-895X (ISSN-L)
- OpenAlex
- W2326136019
- Cited by
- 12
- References
- 61
- Citations by year
- 2025: 1 · 2021: 1 · 2018: 2 · 2014: 4 · 2013: 3 · 2012: 1
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gastroenterology Nursing (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Prometheus
- U.S. Food and Drug Administration
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Keywords
- irritable bowel syndrome, nursing assessment, nurse-patient communication, symptom severity, quality of life, treatment response, chronic diarrhea, constipation, abdominal pain
- MeSH terms
- Female, Humans, Male, Nurse's Role, Irritable Bowel Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Practical Considerations for Recognizing and Managing Severe Irritable Bowel Syndrome. https://app.cochat.ai/papers/10.1097/sga.0b013e31823ff0e8
- The paper
- Harris, L. A., & Heitkemper, M. M. (2012). Practical Considerations for Recognizing and Managing Severe Irritable Bowel Syndrome. Gastroenterology Nursing. https://doi.org/10.1097/sga.0b013e31823ff0e8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.